Familial pulmonary carcinoid tumors

被引:0
|
作者
Oliveira, AM
Tazelaar, HD
Wentzlaff, KA
Kosugi, NS
Hai, N
Benson, A
Miller, DL
Yang, P
机构
[1] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA
[4] Kyoto Univ, Dept Lab Med, Kyoto, Japan
[5] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA
[6] Mayo Clin & Mayo Fdn, Div Gen Thorac Surg, Rochester, MN 55905 USA
关键词
carcinoma; carcinoid; familial; lung; multiple endocrine neoplasia type 1;
D O I
10.1002/1097-0142(20010601)91:11<2104::AID-CNCR1238>3.0.CO;2-I
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND, Pulmonary carcinoid tumors are rare and usually occur sporadically. infrequently, they arise in association with multiple endocrine neoplasia type 1 (MEN1). Familial pulmonary carcinoid tumors not associated with MEN1 have not been described. METHODS. Two sets of first-degree relatives diagnosed with primary pulmonary carcinoid tumors with no clinical features of MEN1 were identified in a pair of siblings and in a mother and daughter. Mutations in the MEN1 gene were sought using polymerase chain reaction analysis on paraffin embedded tissue from two members of one of the families. RESULTS, Histopathologic and immunohistochemical studies confirmed the diagnoses of carcinoid tumors. None of these patients and no family members had features of MEN1. DNA analysis did not detect germline mutations in the MEN1 gene. CONCLUSIONS. The occurrence of familial pulmonary carcinoid tumors in the absence of MEN1 suggests a novel, rare germline mutation specific to the development of pulmonary carcinoids. Cancer 2001;91:2104-9. (C) 2001 American Cancer Society.
引用
收藏
页码:2104 / 2109
页数:6
相关论文
共 50 条
  • [31] Carcinoid tumors of the stomach
    Modlin, IM
    Lye, KD
    Kidd, M
    SURGICAL ONCOLOGY-OXFORD, 2003, 12 (02): : 153 - 172
  • [32] Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
    Travis, WD
    Rush, W
    Flieder, DB
    Falk, R
    Fleming, MV
    Gal, AA
    Koss, MN
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) : 934 - 944
  • [33] Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors
    Pelosi, Giuseppe
    Leon, Maria Elena
    Veronesi, Giulia
    Spaggiari, Lorenzo
    Pasini, Felice
    Viale, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) : 468 - 477
  • [34] A CT-Based Radiomic Signature for the Differentiation of Pulmonary Hamartomas from Carcinoid Tumors
    Cangir, Ayten Kayi
    Orhan, Kaan
    Kahya, Yusuf
    Ugurum Yuecemen, Ayse
    Aktuerk, Islam
    Ozakinci, Hilal
    Gursoy Coruh, Aysegul
    Dizbay Sak, Serpil
    DIAGNOSTICS, 2022, 12 (02)
  • [35] Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts
    Sazonova, Olga
    Manem, Venkata
    Orain, Michele
    Khoshkrood-Mansoori, Babak
    Gaudreault, Nathalie
    Desmeules, Patrice
    Bosse, Yohan
    Joubert, Philippe
    MODERN PATHOLOGY, 2020, 33 (09) : 1712 - 1721
  • [36] The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules
    Daniels, Craig E.
    Lowe, Val J.
    Aubry, Marie-Christine
    Allen, Mark S.
    Jett, James R.
    CHEST, 2007, 131 (01) : 255 - 260
  • [37] Metastatic bronchial carcinoid tumors
    Bouledrak, K.
    Walter, T.
    Souquet, P. J.
    Lombard-Bohas, C.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (01) : 41 - 48
  • [38] Inhibition of mTOR in carcinoid tumors
    Grozinsky-Glasberg, Simona
    Pavel, Marianne
    TARGETED ONCOLOGY, 2012, 7 (03) : 189 - 195
  • [39] Cryotherapy of metastatic carcinoid tumors
    Shapiro, RS
    Shafir, M
    Sung, M
    Warner, R
    Glajchen, N
    ABDOMINAL IMAGING, 1998, 23 (03): : 314 - 317
  • [40] Inhibition of mTOR in carcinoid tumors
    Simona Grozinsky-Glasberg
    Marianne Pavel
    Targeted Oncology, 2012, 7 : 189 - 195